Science and Technology Committee - Written Evidence [Back to Report]
Genomic Medicine

---

Here you can browse the Written Evidence which were ordered by the House of Lords to be printed 2 June 2009.

CONTENTS

Memorandum by the Academy of Medical Sciences

Memorandum by the Advertising Standards Authority

Memorandum by the Almac Group

Memorandum by the Association of Medical Research Charities (AMRC)

Memorandum by the Association for Clinical Cytogenetics (ACC)

Memorandum by AstraZeneca Research & Development

Memorandum by the Biolndustry Association (BIA)

Memorandum by the Biosciences Federation

APPENDIX

Memorandum by Breakthrough Breast Cancer

APPENDIX A

Memorandum by the Breast Cancer Campaign

Memorandum by the British Association for Applied Nutrition & Nutritional Therapy

Memorandum by the British Heart Foundation

Memorandum by the British Society for Ecological Medicine

Memorandum by the British Society for Immunology

Memorandum by GEN2PHEN

Memorandum by the General Medical Council

Memorandum by GenoMed

Memorandum by Genzyme UK & Ireland

Memorandum by Dr Maggie Gregory and Dr Paula Boddington

Memorandum by Harvard Medical School

Memorandum by the Hastings Centre

Memorandum by the Health & Safety Executive (HSE)

Memorandum by the Human Fertilisation and Embryology Authority (HFEA)

Memorandum by the Information Commissioner

Memorandum by the Joint Committee on Medical Genetics (JCMG)

Memorandum by LGC

Memorandum by the National Genetics Reference Laboratory Manchester

Memorandum by the National Genetics Reference Laboratory (Wessex)

Memorandum by the NHS National Genetics Education and Development Centre

Memorandum by Professor Marcus Pembrey FMedSci

Memorandum by Roche Applied Science

Supplementary memorandum by 454 Life Sciences, a Roche Company

Memorandum by the Royal Academy of Engineers

Memorandum by the Royal Pharmaceutical Society of Great Britain

Memorandum by the Sheffield Children's NHS Foundation Trust

Memorandum by the UK Intellectual Property Office (UK-IPO)

Supplementary memorandum by the UK Intellectual Property Office (UK-IPO)—ANNEXES

Annex 1

Annex 2

Annex to Chapter 6

Annex to Chapter 7

Annex to Chapter 10

Memorandum by the University of Montréal

Memorandum by Wyeth

---